Condition
Transcutaneous Vagus Nerve Stimulation
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Not Yet Recruiting2
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07292623Not ApplicableCompleted
Effects of Transcutaneous Vagus Nerve Stimulation in Older Adults
NCT07384845Not ApplicableNot Yet Recruiting
The Role of Transcutaneous Vagus Nerve Stimulation in Treatment of Acute Brain Injury
NCT07198542Not ApplicableEnrolling By Invitation
Treatment of SSD With tcVNS and taVNS
NCT07078058Not ApplicableNot Yet Recruiting
Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy
Showing all 4 trials